These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35032083)

  • 1. Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort.
    Ho A; Leach E; Virani A; Arbour L; Bartels K; Wong EK
    J Genet Couns; 2022 Jun; 31(3):815-828. PubMed ID: 35032083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
    Grutters LA; Christiaans I
    Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.
    van den Heuvel LM; van Teijlingen MO; van der Roest W; van Langen IM; Smets EMA; van Tintelen JP; Christiaans I
    Circ Genom Precis Med; 2020 Oct; 13(5):524-530. PubMed ID: 33079600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees.
    van den Heuvel LM; Huisinga MJ; Hoedemaekers YM; Baas AF; Plantinga M; Henneman L; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2019 Sep; 27(9):1341-1350. PubMed ID: 31053782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory.
    Stava TT; Berge KE; Haugaa KH; Smedsrud MK; Leren TP; Bogsrud MP
    Clin Genet; 2024 Nov; 106(5):585-602. PubMed ID: 39073097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.
    Marleen van den Heuvel L; Stemkens D; van Zelst-Stams WAG; Willeboordse F; Christiaans I
    J Genet Couns; 2020 Oct; 29(5):786-799. PubMed ID: 31889383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
    Vos J; Jansen AM; Menko F; van Asperen CJ; Stiggelbout AM; Tibben A
    Genet Med; 2011 Apr; 13(4):333-41. PubMed ID: 21358410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a chatbot to increase uptake of cascade genetic testing.
    Schmidlen T; Jones CL; Campbell-Salome G; McCormick CZ; Vanenkevort E; Sturm AC
    J Genet Couns; 2022 Oct; 31(5):1219-1230. PubMed ID: 35616645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?
    Hofman N; Tan HL; Alders M; van Langen IM; Wilde AA
    J Am Coll Cardiol; 2010 Jun; 55(23):2570-6. PubMed ID: 20513597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
    Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
    Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cascade testing for inherited cardiac conditions: Risk perception and screening after a negative genetic test result.
    Fusco KM; Hylind RJ; Cirino AL; Harris SL; Lubitz SA; Abrams DJR; Lakdawala NK
    J Genet Couns; 2022 Dec; 31(6):1273-1281. PubMed ID: 35763674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.
    Burke K; Dawson L; Hodgkinson K; Wilson BJ; Etchegary H
    J Community Genet; 2024 Aug; 15(4):387-400. PubMed ID: 39046652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication of genetic information to at-risk relatives during the multidisciplinary monitoring of vascular Ehlers-Danlos syndrome in a French referral clinic.
    Mazzella JM; Adham S; Frank M; Legrand A; Lahlou-Laforêt K; Jeunemaitre X
    J Genet Couns; 2020 Oct; 29(5):828-837. PubMed ID: 31903687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
    Hawranek C; Rosén A; Hajdarevic S
    Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; Baars MJH; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2022 Feb; 30(2):203-210. PubMed ID: 34815540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.